CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Stocks that are likely to record significant movement on bourses today

DSIJ Intelligence 0 1188 Article rating: 2.1

Market on Wednesday ended in the green, overshadowing the global sentiment due to a new strain of COVID-19 found in the UK. Sensex went up by 0.95 per cent, a hike of 437.49 points, and settled at 46,444.18. Nifty too gained, 134.8 points, a 1 per cent gain at 13,601.10. It proved to be a good day for IT stocks with Infosys being one of the top gainers, followed by Hindustan Unilever and Mahindra & Mahindra.  

Parag Milk Foods expands health & nutrition business; stock surges over 6 per cent

DSIJ Intelligence 0 1027 Article rating: 5.0

With the intent of expanding its health & nutrition business, the leading manufacturer & marketer of dairy-based branded products, Parag Milk Foods informed the bourses on Wednesday that it has established state-of-the-art facilities with a capacity to manufacture 40 MT of lactose per day. 

Glenmark Pharma enters into exclusive agreement with Menarini Group; stock ends positively

DSIJ Intelligence 0 1669 Article rating: 4.3

Under this agreement, Glenmark Pharma will be responsible for the development & regulatory approval of the nasal spray by relevant European Regulatory Authorities whereas, Menarini Group will be responsible for the commercialisation of Ryaltris across these markets. 

Bajaj Auto gets nod from Maharashtra Government for Rs 650 crore investment; signs MoU

DSIJ Intelligence 0 916 Article rating: 5.0

Bajaj Auto Limited informed the bourses on Tuesday after the market hours that it has signed a memorandum of understanding (MoU) with the Government of Maharashtra for setting up a manufacturing facility on a proposed investment of Rs 650 crore in Chakan (Maharashtra). 

Aster DM Healthcare shines post announcing clinical excellence hub in Cayman Islands

DSIJ Intelligence 0 782 Article rating: 4.7

Aster DM Healthcare and Cayman Islands Government today announced an agreement for making the Cayman Islands as Aster’s clinical excellence hub for the Western hemisphere, serving North America, the Caribbean region, Canada, Latin & South America. 

NFU Mutual of UK selects Zensar Technologies as strategic tech & digital services partner

DSIJ Intelligence 0 760 Article rating: 4.3

Zensar Technologies announced that it has been selected by NFU Mutual, the UK’s leading rural insurer, to form a new strategic technology and digital relationship to support multiple technologies that underpin a number of the company’s key business systems. 

Hindustan Foods spurts over 9 per cent post announcing Rs 125 crore Capex for a leading FMCG brand

DSIJ Intelligence 0 1549 Article rating: 3.3

Hindustan Foods Limited (HFL) has announced that it will be undertaking a capital expenditure worth Rs 125 crore in the Northern region of India through its wholly-owned subsidiary, HFL Consumer Products Private Limited. 

Birlasoft beating reds; up by 200 per cent in 2020

DSIJ Intelligence 0 1608 Article rating: 3.8

Birlasoft has multiple verticals including energy, manufacturing, banking, financial services & insurance (BFSI). The company also provides digital transformation and integrated solutions to enterprises. The contribution from these verticals is divided and is not dependent on one particular industry thereby, making it a diversified portfolio.

AstraZeneca Pharma opens door for severe & rare asthma treatment; stock slumps 3 per cent

DSIJ Intelligence 0 1225 Article rating: 2.5

AstraZeneca Pharma India Limited informed on Monday that it has been granted permission by Drugs Controller General of India (DCGI) for importing & marketing of Benralizumab 30mg/ml solution for injection (Fasenra™). The medicine helps in treating a severe & rare type of asthma caused mainly in adults. 

ONGC forms identical three crows pattern

Vinayak Gangule 0 976 Article rating: 4.2

The identical three crows’ candlestick is a bearish reversal pattern. The pattern occurs when the bears overtake the bulls during three consecutive trading sessions. The pattern shows three bearish long body candles on the pricing chart with short or no shadows. This pattern usually indicates a weakness in an established uptrend as well as the potential emergence of a downtrend.

ICICI Prudential Life Insurance launches new retirement pension plan

DSIJ Intelligence 0 3629 Article rating: 4.6

On Friday, ICICI Prudential Life Insurance announced that it has launched an innovative retirement plan, offering guaranteed life-long income. The plan is a non-linked non-participating individual annuity product, which provides its customers with an option to choose between immediate and deferred annuity.

Strides Pharma rises nearly 3 per cent on receiving USFDA nod for Oxybutynin Chloride tablets

DSIJ Intelligence 0 1014 Article rating: 4.0

Strides Pharma Science today announced that its wholly-owned subsidiary, Strides Pharma Global Pte Ltd (Singapore) has received approval for Oxybutynin Chloride tablets USP, 5 mg from United States Food & Drug Administration (USFDA). The tablet is therapeutically and bioequivalent equivalent to the reference listed drug (RLD), Ditropan tablets, 5 mg, of Janssen Pharmaceuticals, Inc.

Nifty trend for Friday

DSIJ Intelligence-3 0 1463 Article rating: 4.5

No prizes for guessing! Nifty formed yet another indecisive candlestick pattern on the daily chart today. It’s more or less like hitting 6 sixes in 6 balls as for the sixth day in a row, Nifty has formed this pattern. There are high chances that we would once again enter into a phase of consolidation after hitting the targets of 13,800-13,840.

Where To Invest In : 2021

Ninad Ramdasi 0 1786 Article rating: 4.3

Very few years in the history of equity markets have been as eventful as 2020. That makes 2021 extremely interesting for both bears and bulls as the markets are precariously poised at record highs. Geyatee Deshpande discusses how the year 2020 has been for equity investors and Vinayak Gangule shares his technical view on the markets while Yogesh Supekar forecasts what one can expect in 2021 even as the DSIJ research team highlights its ‘where to invest in 2021’ portfolio in this cover story 

Kerbside

Ninad Ramdasi 0 856 Article rating: No rating

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals.

Review

Ninad Ramdasi 0 853 Article rating: No rating

In this edition, we have reviewed KNR Constructions Ltd. and National Aluminium Company Ltd. We suggest our reader-investors to HOLD in KNR Constructions Ltd. and National Aluminium Company Ltd.

Data Bank & Dividend

Ninad Ramdasi 0 1022 Article rating: No rating

This is a super house of financial data on 3500 corporates with up to date information. In the Magazine version the top 1100 -1400 companies are covered while the data on the entire 3500 companies is available in excel format for subscribers to download.

MF Query Board

Ninad Ramdasi 0 587 Article rating: No rating

Readers are requested to send only one query at a time so that more readers get a chance. Have questions relating to any aspect of personal finance. Ask DSIJ at editorial@DSIJ.in and get your queries resolved.

Fund of Fortnight

Ninad Ramdasi 0 950 Article rating: No rating

This is our mutual fund recommendation. Every fortnight ,we recommend one open-ended equity diversified fund that has the best potential of returns for the next one year considering its constituents remain the same.

RSS
First320321322323325327328329Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR